




































Population The role of the microenvironment in the 
pathogenesis of neoplastic disease is increasingly being 
appreciated. Starting from the report of Mintz and 
Illmensee [1], describing the generation of normal 
genetically mosaic mice from malignant 
teratocarcinoma cells, several studies have 
demonstrated that the phenotype of pre-neoplastic and 
neoplastic cell populations can be profoundly 
modulated by external cues emanating from the 
surrounding microenvironment [2-5]. Furthermore, it 
has been documented that specific gene-expression 
profiles in non-cancerous tissue are able to predict 
recurrence and survival in patients with hepatocellular 
carcinoma (HCC), again pointing to the critical role of 
the surrounding microenvironment in the natural history 






































our laboratory have indicated that a growth-
constrained/senescent tissue environment is able to 
generate a powerful driving force for the selective 
expansion of pre-neoplastic hepatocytes in the liver, 
leading to their progression to HCC [8]. Exposure to 
retrorsine (RS), a naturally-occurring pyrrolizidine 
alkaloid, impairs liver regeneration and induces 
extensive hepatocyte senescence in rat liver [9-10]. 
When pre-neoplastic cells isolated from hepatic nodules 
were transplanted in RS-treated livers, they grew 
rapidly and evolved into HCC; however, the same cell 
preparation was unable to expand and progress 
following injection into untreated, syngeneic normal 
hosts [8].  
 
These observations provide a rationale for the 
hypothesis that targeting a neoplastic-prone tissue 

















that  the  latter  can be a  target  for preventive or  therapeutic  strategies. We  tested  the possibility  that  re‐normalizing a
senescent, neoplastic‐prone  tissue microenvironment would exert a modulatory effect on  the emergence of neoplastic
disease. Rats were exposed  to a protocol  for  the  induction of hepatocellular carcinoma  (HCC). Using an orthotopic and
syngeneic system for cell transplantation, one group of animal was then delivered 8 million normal hepatocytes, via the




exposed  to  the  carcinogenic  protocol,  while  they  returned  to  near  control  values  in  the  group  receiving  hepatocyte
transplantation.  These  results  support  the  concept  that  strategies  aimed  at  normalizing  a  neoplastic‐prone  tissue
landscape can modulate progression of neoplastic disease.  
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landscape may represent a valuable approach to 
modulate the evolution of carcinogenic process [11-
13]. Recently, we have obtained evidence to indicate 
that orthotopic transplantation of normal hepatocytes 
in animals previously exposed to a carcinogenic 
regimen exerts a delaying effect on the growth of early 
preneoplastic lesions [14]. In the present studies, we 
have extended this observation and explored the 
possible biological and molecular mechanisms 
underlying this phenomenon. Neoplastic process was 
induced in rat liver through sequential exposure to 
diethylnitrosamine (DENA) and RS. Normal 
hepatocytes transplanted following the carcinogenic 
protocol were able to reduce the incidence of 
preneoplastic and neoplastic lesions at the end of 1 
year. This was associated with clearance of RS-





The induction of hepatocellular carcinoma following 
exposure to DENA+RS 
 
As already mentioned, naturally occurring pyrrolizidine 
alkaloids, including RS, are known for their ability to 
promote the growth of early hepatic nodules in initiated 
rat liver [15]. However, no studies have been reported 
to date on the long term effects of these agents in 
animals previously given a carcinogen. In the present 
experiments, rats were administered DENA and RS 
(two single injections, 10 days apart), and they were 
killed 1 year later. As predicted, multiple pre-neoplastic 
and neoplastic hepatocellular lesions, ranging in size 
from a few mm to 2.5 cm in diameter, were observed in 
all animals exposed to this protocol (figure 1, panel A). 


















sence of large, advanced hepatocyte nodules in all liver 
samples in this group, while trabecular HCC was 
diagnosed in 4 out of 8 rats (figure 1, panel B). 
 
Normal hepatocyte transplantation delays the 
emergence of HCC induced by DENA+RS 
 
Based on the above findings, we next considered the 
effect of normal hepatocyte transplantation on the 
incidence of hepatic nodules and HCC following 
exposure to DENA+RS. Results are reported figure 2 
and table 1. Major differences were already evident 
upon macroscopic examination. The liver of 
DENA+RS-treated animals displayed slightly increased 
stiffness compared to normal, with irregular margins 
and finely granular surface; however, these changes 
were largely reversed in rats receiving the infusion of 
normal cells (figure 2, panels A and B). Most notably, 
the presence of large nodular lesions and overall tumour 
burden in the liver were greatly reduced in the latter 
group (figure 2, panel C); only 2 out of 8 rats in this 
group had nodules >5mm in diameter; strikingly, in 2 
animals no macroscopic lesions were observed. 
Histological analysis on H&E stained liver samples 
confirmed and extended these results: overt HCC was 
found in 4 out of 8 animals given DENA+RS, as 
mentioned in the preceding paragraphs; however, no 
HCCs were present in the group receiving normal 
hepatocyte transplantation following the carcinogenic 
protocol (table 1). Proliferating hepatocytes were 
readily observed in hepatic nodules and HCC in animals 
exposed to DENA+RS, as expected (figure 2, panel D); 
however, they were fewer in GST 7-7-positive lesions 
from the group receiving hepatocyte transplantation 
(figure 2, panel E); in the latter group, areas of 
repopulated liver displayed scattered BrdU-positive 






































































































































 Number of animals with: 
 Preneoplastic nodules HCC 
 ≤5mm >5mm  
DENA + RS 8/8 7/8 4/8 
DENA + RS + Tx 6/8 2/8 0/8 
Relative Risk 0.7500 0.2857 0 
P value ns <0.05 <0.05 
 
 





included  in  this  plot.  ***Significantly  different  from  non‐transplanted  animals:  nodules  <4mm,  P<0.005;
nodules 4‐6mm, P<0.001; nodules >6mm, P<0.005. Panels D‐F: immunohistochemical analysis of liver sections
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Normal hepatocyte transplantation results in the 
clearance of DENA+RS-induced senescent hepa-
tocytes 
 
As mentioned in the Introduction, recent findings have 
indicated that exposure to RS induces extensive 
hepatocyte senescence in rat liver [10]. Although cell 
senescence can represent a fail safe mechanism to alt 
neoplastic progression of altered cells [17], it is now 
well established that it can also contribute to the 
emergence of the neoplastic phenotype, possibly 
through secretion of a host of factors, variably referred 
to as senescence-associated secretory phenotype 
(SASP) [18] or senescence-messaging secretome 
(SMS) [19], and comprising cytokines, growth factors 
and proteases. Based on this information, it became 
important to determine the presence of hepatocyte 
senescence in animals treated with DENA+RS or 




































ed to cell senescence were highly expressed in animals 
treated with DENA+RS and killed 4 months later; 
these included the senescence-associated β-
galactosidase (SA-β-gal), (panel A); and the 
phosphorylated form of H2A histone family, member 
X (γ-H2AX), which is considered as a marker of 
persistent activation of a DNA damage response and a 
trigger of cell senescence (panel D). However, both 
changes were almost completely reversed in animals 
given DENA+RS followed by hepatocyte 
transplantation. Transplanted hepatocytes were able to 
extensively repopulate the host liver; this effect was 
already prominent at 4 months post-injection (Figure 
3, panel C), and persisted after 1 year (data not 
shown); it was associated with decreased expression of 
both SA-β-gal and γ-H2AX, which were virtually 
absent in repopulated areas of the liver and were only 
detected in residual portions of endogenous 









































treated  livers  (panels  A,  D),  while  their  levels  were  markedly  reduced  in  animals  receiving  hepatocyte
transplantation (panels B, C, E, F). In the latter group, extensive repopulation of the recipient liver was observed





































Hepatocyte transplantation reverses biochemical 
markers of hepatocyte senescence and SASP 
 
An intriguing interpretation of cell senescence 
postulates that this unique phenotype emerges when a 
cell integrates two types of signals: one that reads for 
growth and one that imposes a block in the replicative 
cycle [20,21]. For example, DNA damaging agents do 
not induce senescence in quiescent cells; however, they 
do so if the presence of persistent DNA damage and cell 
cycle arrest is coupled with growth promoting stimuli 
[21]. Under these conditions, cells switch on the 
senescence program and express markers related to both 
cell cycle block and growth stimulation. In line with this 
postulation, both the cyclin-dependent kinase inhibitor, 
p21, and the positive regulator cyclin D1 were found to 
be over-expressed in rats exposed to DENA+RS and 
killed 4 months thereafter (figure 4, panels A and B). 
Furthermore, a main component of SASP/SMS, namely 
the pro-inflammatory cytokine IL-6, was also over-
expressed in DENA+RS-treated animals. Both findings 
were in agreement with those reported following 

































Remarkably, these changes were strongly counteracted 
by transplantation of normal hepatocytes: in fact, the 
expression of p21, cyclin D1 and IL-6 returned to near-
control levels in animals receiving normal cells 
following exposure to the carcinogenic protocol. (figure 




The results of these studies indicate that transplantation 
of normal hepatocytes in a neoplastic-prone liver 
microenvironment delays the growth of hepatic nodules 
and the emergence of HCC; furthermore, this effect is 
associated with clearance of senescent hepatocytes 
induced by the carcinogenic protocol. 
 
Over a decade ago, we reported that pre-neoplastic 
hepatocytes grew very rapidly and progressed to HCC 
upon transplantation into a host liver pre-treated with 
RS; however, the same cell population was unable to 
expand following implantation into the liver of a 
normal, un-treated recipient [8]. Recent studies, aimed 
at defining the biological and molecular determinants of 
Figure  4.  Hepatocyte  transplantation  reverses  the  RS‐induced  senescent  phenotype.
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the RS-induced effect, revealed the presence of 
extensive hepatocyte senescence in rat liver exposed to 
the alkaloid. Based on those findings, it was suggested 
that cell senescence and the associated SASP/SMS are 
possibly involved in the induction of the RS-associated 
neoplastic-prone tissue microenvironment [10]. In fact, 
it is now widely recognized that the senescence 
phenotype, while representing a fail-safe mechanism to 
avoid the risk of malignant transformation in cells 
harbouring damaged DNA or activated oncogenes 
[16,17,22,23], can also foster the emergence of 
premalignant and malignant cells [18,19,24,25], 
including their acquisition of metastatic potential [26] 
and resistance to chemotherapy [27,28]. These effects 
are at least partly mediated by a host of secreted factors, 
referred to as SASP/SMS and comprising cytokines, 
growth factors and proteases [18,19]. Among other 
products, the pro-inflammatory cytokine IL-6 has been 
attributed a prominent role both as a mediator of SASP 
effects and in reinforcing the senescence phenotype 
[24]. Moreover, cell senescence and SASP have been 
linked to chronic inflammation [29], adding yet another 
facet to the complex relationship between cancer, aging, 
and the immune response [30,31]. Interestingly, cell 
senescence has been reported in association with major 
risk factors for human neoplasia, including aging, 
cigarette smoke [32], UV light [33] and liver cirrhosis 
[34]. Indeed, the presence of hepatocyte senescence has 
long been documented during the evolution of chronic 
liver disease [35]. A recent study suggests that 
parameters related to cell senescence predict progression 
in non-alcoholic fatty liver disease (NAFLD) [36]. 
Moreover, a specific role for IL-6, together with TNF, 
has been proposed in the pathogenesis of liver 
inflammation and cancer associated with dietary and 
genetic obesity [37]. Thus, it appears that the tissue 
microenvironment induced by RS in rat liver, which 
strongly promotes the neoplastic process, shares 
intriguing similarities with chronic alterations associated 
with increased risk of liver cancer in humans.  
 
In the present studies we tested the possibility that 
normal hepatocyte transplantation would reverse 
alterations induced by RS in the liver 
microenvironment, thereby modulating its tumour 
promoting potential. To this end, animals were 
sequentially exposed to DENA and RS, followed by 
two injections of hepatocytes freshly isolated from 
normal syngenic donors [14]. At end of 1 year, all 
animals treated with DENA+RS developed large liver 
tumours, with 50% (4/8) incidence of HCC. By 
contrast, the number of nodules were greatly reduced in 
rats receiving normal hepatocyte transplantation; most 
importantly, no animal in this group showed 
histological evidence of HCC (figure 2 and Table 1). 
The liver of transplanted animals was extensively 
repopulated by donor-derived cells, resulting in the 
clearance of DENA+RS-induced senescent hepatocytes. 
Only residual hepatocyes expressing SA-β-Gal or γ-
H2AX were found in these animals, and they were 
confined to areas of non-repopulated liver (figure 3); 
furthermore, the expression of cyclin D1, p21 and the 
SASP-associated cytokine IL-6 were markedly reduced 
to near control values. In summary, normal hepatocyte 
transplantation is able to delay DENA+RS-induced 
carcinogenic process and it is also associated with 
extensive remodeling of the tissue landscape, consisting 
in the massive replacement of resident senescent 
hepatocytes with phenotypically normal cells. It is 
noteworthy that our results are reminiscent of those 
reported by the group of the DeGregori in the 
hematopoietic system: it was observed that 
transplantation of young, normal bone marrow cells was 
able to prevent the clonal expansion and 
leukemogenesis mediated by initiated progenitors in the 
context of an aged or previously irradiated bone marrow 
microenvironment  [38,39]. 
 
In a recent report, Kang et al. described the protective 
effect of immune-mediated clearance of N-ras-
expressing senescent hepatocytes on liver cancer 
development in mice [40]. The effect was attributed to 
the putative preneoplastic nature of oncogene-
transduced senescent cells, whose removal by a T-cell 
specific response was therefore considered as directly 
responsible for the reduced incidence of HCC [40]. 
While any direct involvement of the immune system 
was not investigated in our present study, our findings 
appear difficult to reconcile with the above proposition. 
In fact, there is no evidence that RS-induced senescent 
hepatocytes display any direct pre-neoplastic potential 
[41]; on the other hand, they are able to support the 
growth of transplanted nodular hepatocytes and their 
progression to HCC [8]. Thus, it appears that, under the 
conditions described in our studies, the role of cell 
senescence is to promote the growth of carcinogen-
induced altered cells, possibly through the effect(s) of 
SASP/SMS components, including IL-6 [42]. 
Replacement of senescent hepatocytes by normal 
transplanted cells results in the attenuation of such 
promoting effect and a delay in the emergence of 
preneoplastic and neoplastic lesions. Interestingly, a 
similar paradigm could be applicable to the increased 
cancer incidence associated with aging [43]. 
 
Taken together, these findings reinforce the concept that 
strategies aimed at preserving and/or re-establishing a 
normal tissue microenvironment represent an effective 
approach towards limiting the impact of neoplastic 
disease. Furthermore, they highlight the role of 
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senescent cells in fuelling carcinogenesis in a 




Animals and treatments. Liver carcinogenesis was 
induced using a sequential exposure to diethyl-
nitrosamine (DENA) and retrorsine (RS) [14]. Male 
Fischer 344, rats of 4 weeks of age were injected with 
DENA (160 mg/kg, i.p.), followed by a single dose of 
RS (30 mg/kg, i.p.), given 10 days after DENA 
administration. Two weeks later, animals were divided 
into 2 groups of 12 rats each: group 1 received no 
further treatment, while group 2 was given two 
injections of hepatocytes isolated from a normal 
syngenic donor, containing 4x106 cells each, two weeks 
apart. Animals from each group were killed at either 4 
months (4 rats) or 12 months (the remaining 8 rats) after 
DENA administration. Starting 24 hours before killing, 
animals were given 3 injections of 5‘-bromo-deoxy-
uridine (BrdU, 50 mg/kg, i.p.) every 8 hours. All 
experiments were approved by the University of 
Cagliari Ethical Committee for Animal 
Experimentation; all animals received humane care in 
accordance with NIH Guidelines for the care and use of 
animals. Hepatic lesions were microscopically classified 
according to published criteria [44].  
 
Hepatocyte isolation and transplantation. Hepatocytes 
for transplantation were isolated from a 6-wk old donor, 
according to a two-step collagenase perfusion technique 
[45]. Cell viability, determined by trypan blue exclusion 
at the end of the isolation procedure, was >90%. 
Animals were anesthetized and a small incision (about 1 
cm) was performed in the upper abdominal wall; 
hepatocytes, suspended in PBS (1x107/ml), were then 
delivered through a branch of the mesenteric veins, 
using a syringe with a 26-gauge needle. The fate of 
donor-derived cells in the recipient liver was followed 
using the F344-dipeptidyl-peptidase type IV (DPP-IV)-
deficient model for cell transplantation [46]. Donor 
hepatocytes were isolated from animals expressing the 
marker enzyme (DPP-IV-positive), while DPP-IV-
deficient rats were used as recipients. Since the Fischer 
344 rat is a syngenic strain, no immunosuppression was 
required for successful cell transplantation. 
 
Histochemical and immunohistochemical methods. 
After sacrifice, livers were removed and samples were 
taken from each lobe to be either frozen for cryostat 
sections or fixed in buffered formalin for standard 
histological analysis and immunohistochemistry. In 
animals killed at 12 months, liver lobes were cut into 1-
2 mm-thick slices and were macroscopically examined 
for the presence of hepatic nodules/tumors or any other 
evident lesion. The extent of liver repopulation in 
transplanted animals was monitored in cryostat sections 
stained for DPP-IV expression, using histochemical 
detection methods. Double staining for BrdU (DAKO, 
Glostrup, Denmark) and glutathione-S-transferase 7-7 
(GST 7-7, Santa Cruz, Santa Cruz, CA) was performed 
on frozen sections, previously fixed in cold 1% acetic 
acid/ethyl alcohol and boiled in 0,01M Sodium Citrate, 
pH 6.0. 
 
Staining for SA-β-gal was performed according to 
published procedures [47]. Immediately before staining, 
X-Gal stock solution was prepared by dissolving 
20mg/ml X-Gal (Invitrogen, Carlsbed, CA) in 
dimetylformamide. SA-β-Gal staining solution was 
prepared as follows: 1 mg/ml of X-Gal stock solution 
were dissolved in 40 mM citric acid in sodium 
phosphate, pH 6.0/5 mM potassium ferrocyanide/5 mM 
potassium ferricyanide/150 mM NaCl/2 mM MgCl2. 
Frozen sections of 10-µm thickness were fixed for 5’ in 
4% formaldehyde/0.5% glutaraldehyde at 4°C, washed 
in PBS and incubated in fresh SA-β-Gal staining 
solution for 16h at 37°C. Sections were counterstained 
with Hematoxylin. 
 
Immunofluorescence. Immunoflorescence staining for 
γ-H2AX and CD26 was performed on frozen sections, 
following fixation in acetone. Slides were blocked for 
30’, incubated with primary antibodies (H2AX: Abcam, 
Cambridge, MA; CD26: BD Pharmigen, San Jose, CA) 
for 1 h at RT, then incubated with Alexa 488- and Alexa 
555-conjugated secondary antibodies (Life 
Technologies, Carlsbad, CA). Slides were 
counterstained with DAPI and images were acquired 
with an IX71 fluorescence microscope with CCD 
camera (Olympus, Tokyo, Japan).  
 
Western Blot. Liver tissue samples were homogenized 
in RIPA lysis buffer containing Protease Inhibitors, then 
centrifuged at 12000 rpm for 30’ at 4°C. Protein 
concentration in supernatants was measured using the 
BCA method [48]. Samples (20µg protein) were 
prepared in Laemmli buffer, boiled at 95°C for 5’ then 
loaded into SDS-PAGE precast gels (Biorad, Hercules, 
CA) and run under denaturing conditions. Proteins were 
transferred onto nitrocellulose membranes (GE, 
Fairfield, CT), blocked with 5% non-fat milk for 1 h, 
then incubated with primary antibodies for Cyclin D1 
(Sigma, St. Louis, MO), p21 (Santa Cruz, Santa Cruz, 
CA) NF-κB, TNF-α, IL-6 and β-Actin (Abcam) 
overnight at 4°C. Membranes were washed  and 
incubated for 2 h with the appropriate secondary 
antibody conjugated with HRP. Protein bands were 
detected using a chemoluminescent substrate (Biorad) 
and imaged onto Kodak film. 
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Imaging and Statistical analysis. Relative risk of 
developing preneoplastic/neoplastic lesions was 
calculated for both experimental groups, as shown in 
table 1. Chi-square test was used to evaluate statistical 
significance. Histological images and western blots 
were processed for quantification with Image Pro 
Premier software (Media Cybernetics, Rockville, MD). 
Results are presented as mean±S.E; two-tailed Student t 
test was used to evaluate results, with a lowest level of 
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